Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 2

Status

Completed 5Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5Genitourinary 3Thoracic 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Osteoporosis 5Breast Neoplasms 5Bone Diseases, Metabolic 3

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Risedronic Acid × Breast × Clear all
NCT00354302 2020-04-02

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Canadian Cancer Trials Group

Phase 3 Completed
497 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00485953 2017-10-13

REBBeCA II

University of Pittsburgh

Phase 4 Completed
109 enrolled 11 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00054418 2016-07-13

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
216 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00859703 2013-10-31

RISAROS

Hospices Civils de Lyon

Phase 3 Completed
20 enrolled
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00082277 2011-01-26

SABRE

AstraZeneca

Phase 4 Completed
237 enrolled
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡